Literature DB >> 33595806

Association of SHANK Family with Neuropsychiatric Disorders: An Update on Genetic and Animal Model Discoveries.

Lily Wan1, Du Liu1,2, Wen-Biao Xiao1, Bo-Xin Zhang1, Xiao-Xin Yan3, Zhao-Hui Luo4, Bo Xiao5.   

Abstract

The Shank family proteins are enriched at the postsynaptic density (PSD) of excitatory glutamatergic synapses. They serve as synaptic scaffolding proteins and appear to play a critical role in the formation, maintenance and functioning of synapse. Increasing evidence from genetic association and animal model studies indicates a connection of SHANK genes defects with the development of neuropsychiatric disorders. In this review, we first update the current understanding of the SHANK family genes and their encoded protein products. We then denote the literature relating their alterations to the risk of neuropsychiatric diseases. We further review evidence from animal models that provided molecular insights into the biological as well as pathogenic roles of Shank proteins in synapses, and the potential relationship to the development of abnormal neurobehavioral phenotypes.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC part of Springer Nature.

Entities:  

Keywords:  Autism; Neurodevelopment; Neuropsychiatric disorders; Synaptic plasticity; Synaptic transmission

Mesh:

Substances:

Year:  2021        PMID: 33595806     DOI: 10.1007/s10571-021-01054-x

Source DB:  PubMed          Journal:  Cell Mol Neurobiol        ISSN: 0272-4340            Impact factor:   5.046


  110 in total

1.  Synaptic scaffolding proteins in rat brain. Ankyrin repeats of the multidomain Shank protein family interact with the cytoskeletal protein alpha-fodrin.

Authors:  T M Böckers; M G Mameza; M R Kreutz; J Bockmann; C Weise; F Buck; D Richter; E D Gundelfinger; H J Kreienkamp
Journal:  J Biol Chem       Date:  2001-08-16       Impact factor: 5.157

2.  Disruption of the ProSAP2 gene in a t(12;22)(q24.1;q13.3) is associated with the 22q13.3 deletion syndrome.

Authors:  M C Bonaglia; R Giorda; R Borgatti; G Felisari; C Gagliardi; A Selicorni; O Zuffardi
Journal:  Am J Hum Genet       Date:  2001-06-18       Impact factor: 11.025

3.  Mutations in the SHANK2 synaptic scaffolding gene in autism spectrum disorder and mental retardation.

Authors:  Simone Berkel; Christian R Marshall; Birgit Weiss; Jennifer Howe; Ralph Roeth; Ute Moog; Volker Endris; Wendy Roberts; Peter Szatmari; Dalila Pinto; Michael Bonin; Angelika Riess; Hartmut Engels; Rolf Sprengel; Stephen W Scherer; Gudrun A Rappold
Journal:  Nat Genet       Date:  2010-05-16       Impact factor: 38.330

4.  C-terminal synaptic targeting elements for postsynaptic density proteins ProSAP1/Shank2 and ProSAP2/Shank3.

Authors:  Tobias M Boeckers; Thomas Liedtke; Christina Spilker; Thomas Dresbach; Jürgen Bockmann; Michael R Kreutz; Eckart D Gundelfinger
Journal:  J Neurochem       Date:  2005-02       Impact factor: 5.372

5.  Prevalence of SHANK3 variants in patients with different subtypes of autism spectrum disorders.

Authors:  Luigi Boccuto; Maria Lauri; Sara M Sarasua; Cindy D Skinner; Daniela Buccella; Alka Dwivedi; Daniela Orteschi; Julianne S Collins; Marcella Zollino; Paola Visconti; Barb Dupont; Danilo Tiziano; Richard J Schroer; Giovanni Neri; Roger E Stevenson; Fiorella Gurrieri; Charles E Schwartz
Journal:  Eur J Hum Genet       Date:  2012-08-15       Impact factor: 4.246

6.  Proline-rich synapse-associated protein-1/cortactin binding protein 1 (ProSAP1/CortBP1) is a PDZ-domain protein highly enriched in the postsynaptic density.

Authors:  T M Boeckers; M R Kreutz; C Winter; W Zuschratter; K H Smalla; L Sanmarti-Vila; H Wex; K Langnaese; J Bockmann; C C Garner; E D Gundelfinger
Journal:  J Neurosci       Date:  1999-08-01       Impact factor: 6.167

7.  Genetic association between SHANK2 polymorphisms and susceptibility to autism spectrum disorder.

Authors:  Ye Bai; Shuang Qiu; Yan Li; Yong Li; Weijing Zhong; Meijuan Shi; Xiaojuan Zhu; Huiyi Jiang; Yaqin Yu; Yi Cheng; Yawen Liu
Journal:  IUBMB Life       Date:  2018-06-22       Impact factor: 3.885

8.  Deficits in the Proline-Rich Synapse-Associated Shank3 Protein in Multiple Neuropsychiatric Disorders.

Authors:  Peter N Alexandrov; Yuhai Zhao; Vivian Jaber; Lin Cong; Walter J Lukiw
Journal:  Front Neurol       Date:  2017-12-11       Impact factor: 4.003

9.  Brain region-specific disruption of Shank3 in mice reveals a dissociation for cortical and striatal circuits in autism-related behaviors.

Authors:  Alexandra L Bey; Xiaoming Wang; Haidun Yan; Namsoo Kim; Rebecca L Passman; Yilin Yang; Xinyu Cao; Aaron J Towers; Samuel W Hulbert; Lara J Duffney; Erin Gaidis; Ramona M Rodriguiz; William C Wetsel; Henry H Yin; Yong-Hui Jiang
Journal:  Transl Psychiatry       Date:  2018-04-27       Impact factor: 6.222

10.  Molecular mechanisms generating and stabilizing terminal 22q13 deletions in 44 subjects with Phelan/McDermid syndrome.

Authors:  Maria Clara Bonaglia; Roberto Giorda; Silvana Beri; Cristina De Agostini; Francesca Novara; Marco Fichera; Lucia Grillo; Ornella Galesi; Annalisa Vetro; Roberto Ciccone; Maria Teresa Bonati; Sabrina Giglio; Renzo Guerrini; Sara Osimani; Susan Marelli; Claudio Zucca; Rita Grasso; Renato Borgatti; Elisa Mani; Cristina Motta; Massimo Molteni; Corrado Romano; Donatella Greco; Santina Reitano; Anna Baroncini; Elisabetta Lapi; Antonella Cecconi; Giulia Arrigo; Maria Grazia Patricelli; Chiara Pantaleoni; Stefano D'Arrigo; Daria Riva; Francesca Sciacca; Bernardo Dalla Bernardina; Leonardo Zoccante; Francesca Darra; Cristiano Termine; Emanuela Maserati; Stefania Bigoni; Emanuela Priolo; Armand Bottani; Stefania Gimelli; Frederique Bena; Alfredo Brusco; Eleonora di Gregorio; Irene Bagnasco; Ursula Giussani; Lucio Nitsch; Pierluigi Politi; Maria Luisa Martinez-Frias; Maria Luisa Martínez-Fernández; Nieves Martínez Guardia; Anna Bremer; Britt-Marie Anderlid; Orsetta Zuffardi
Journal:  PLoS Genet       Date:  2011-07-14       Impact factor: 5.917

View more
  2 in total

Review 1.  Genetic Findings as the Potential Basis of Personalized Pharmacotherapy in Phelan-McDermid Syndrome.

Authors:  Brianna Dyar; Erika Meaddough; Sara M Sarasua; Curtis Rogers; Katy Phelan; Luigi Boccuto
Journal:  Genes (Basel)       Date:  2021-07-30       Impact factor: 4.096

Review 2.  Shankopathies in the Developing Brain in Autism Spectrum Disorders.

Authors:  Yukti Vyas; Juliette E Cheyne; Kevin Lee; Yewon Jung; Pang Ying Cheung; Johanna M Montgomery
Journal:  Front Neurosci       Date:  2021-12-22       Impact factor: 4.677

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.